Login / Signup

Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond.

Jonathan CorrenChristopher E BrightlingLouis-Philippe BouletCeleste PorsbjergMichael E WechslerAndrew Menzies-GowChristopher S AmbroseBill CookNeil MartinJoseph SpahnJean-Pierre Llanos
Published in: The European respiratory journal (2023)
Keyphrases
  • chronic obstructive pulmonary disease
  • emergency department
  • combination therapy
  • smoking cessation